Parabon NanoLabs, Inc., a subsidiary of Parabon Computation, Inc., is a privately held Delaware C-Corporation established in 2008. Other than an angel investment early in the company's history and a CIT GAP BioLife Fund award, Parabon NanoLabs has been funded entirely from product licensing and non-dilutive grants and contracts.
Through its use of Parabon Computation's computational services and software tools, Parabon NanoLabs develops next-generation therapeutic and forensic products by leveraging the enormous power of DNA.
Interested investors may contact us for more information.
